A Study of Intravenous XMT-1107 in Patients With Advanced Solid Tumors
NCT01011972
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
52
Enrollment
INDUSTRY
Sponsor class
Conditions
Neoplasm Metastasis
Interventions
DRUG:
XMT-1107
Sponsor
Mersana Therapeutics